Newsletter Archive

1. 04.23.25 -- Establishing Analytical Methods For mRNA-Based Therapies 4/23/2025
   04/23/25 Advancing RNA Newsletter
2. 04.21.25 -- Bringing Your mRNA-Based Drug From Pre-Clinical To Commercial 4/21/2025
   04/21/25 Advancing RNA Newsletter
3. 04.16.25 -- Britney Spears/ Take On mRNA Platform Analytics 4/16/2025
   04/16/25 Advancing RNA Newsletter
4. 04.10.25 -- Navigating Clinical Trial Trends In 2025 4/10/2025

   04/10/25 Advancing RNA Newsletter

5. 04.09.25 -- Is The mRNA Payload The Real MVP Of Targeted Delivery? 4/9/2025
   04/09/25 Advancing RNA Newsletter
6. 04.02.25 -- Understanding The New MHRA Guidance For mRNA Immunotherapies 4/2/2025
   04/02/25 Advancing RNA Newsletter
7. 03.26.25 -- The mRNA Industry's 3 Big Wishes For CDMOs 3/26/2025
   03/26/25 Advancing RNA Newsletter
8. 03.24.25 -- Oncology CRO Services 3/24/2025
   03/24/25 Advancing RNA Newsletter
9. 03.21.25 -- Advancements In The Global Clinical Trial Landscape 3/21/2025

   03/21/25 Advancing RNA Newsletter

10. 03.19.25 -- DNA Quality For IVT: What Do We (Really) Know? 3/19/2025
    03/19/25 Advancing RNA Newsletter